| BSBMTCT Centres - UK and ROI 1st Transplant ONLY | Allografts: | Autografts: | All HSCT | CAR-T | Gene Therapy | ||||||||||||||||
| Disease: | BM | PBSC | CB | Total Allo | BM | PBSC | CB | Total Auto | Totals | Allo | Auto | Total | Total | ||||||||
| AML | 23 | 600 | 50 | 673 | 0 | 1 | 0 | 1 | 674 | 10 | 0 | 10 | 0 | ||||||||
| ALL | 30 | 152 | 16 | 198 | 0 | 1 | 0 | 1 | 199 | 3 | 102 | 105 | 0 | ||||||||
| CML | 3 | 52 | 1 | 56 | 0 | 0 | 0 | 0 | 56 | 0 | 0 | 0 | 0 | ||||||||
| CLL inc. PLL | 0 | 18 | 0 | 18 | 0 | 0 | 0 | 0 | 18 | 0 | 1 | 1 | 0 | ||||||||
| MDS or MDS/MPN | 6 | 191 | 3 | 200 | 0 | 0 | 0 | 0 | 200 | 1 | 0 | 1 | 0 | ||||||||
| MPN | 2 | 79 | 2 | 83 | 0 | 0 | 0 | 0 | 83 | 0 | 0 | 0 | 0 | ||||||||
| PCD: Multiple Myeloma | 0 | 5 | 0 | 5 | 1 | 1663 | 0 | 1664 | 1669 | 0 | 7 | 7 | 0 | ||||||||
| PCD: Other | 0 | 0 | 0 | 0 | 0 | 36 | 0 | 36 | 36 | 0 | 0 | 0 | 0 | ||||||||
| HL | 1 | 39 | 0 | 40 | 0 | 186 | 0 | 186 | 226 | 0 | 0 | 0 | 0 | ||||||||
| NHL | 3 | 75 | 0 | 78 | 0 | 507 | 0 | 507 | 585 | 0 | 431 | 431 | 0 | ||||||||
| Solid Tumours | 0 | 1 | 0 | 1 | 0 | 127 | 0 | 127 | 128 | 0 | 6 | 6 | 0 | ||||||||
| BM Aplasia - SAA | 36 | 50 | 0 | 86 | 0 | 0 | 0 | 0 | 86 | 0 | 0 | 0 | 0 | ||||||||
| BM Aplasia - other | 9 | 15 | 1 | 25 | 0 | 0 | 0 | 0 | 25 | 0 | 0 | 0 | 0 | ||||||||
| Thalassaemia | 10 | 4 | 0 | 14 | 0 | 0 | 0 | 0 | 14 | 0 | 0 | 0 | 3 | ||||||||
| Sickle Cell | 22 | 18 | 0 | 40 | 0 | 0 | 0 | 0 | 40 | 0 | 0 | 0 | 1 | ||||||||
| Inborn Errors of Immunity | 16 | 68 | 0 | 84 | 0 | 0 | 0 | 0 | 84 | 0 | 0 | 0 | 2 | ||||||||
| Inborn Errors of Metabolism | 10 | 4 | 7 | 21 | 0 | 0 | 0 | 0 | 21 | 0 | 0 | 0 | 3 | ||||||||
| Auto-Immune Diseases | 1 | 2 | 0 | 3 | 0 | 74 | 0 | 74 | 77 | 0 | 1 | 1 | 0 | ||||||||
| Others (incl. Histiocytosis) | 2 | 16 | 0 | 18 | 0 | 5 | 0 | 5 | 23 | 0 | 0 | 0 | 0 | ||||||||
| Totals 1st HSCT/CAR-T/GT | 174 | 1389 | 80 | 1643 | 1 | 2600 | 0 | 2601 | 4244 | 14 | 548 | 562 | 9 | ||||||||
| Non 1st HSCT/CAR-T/GT | 7 | 66 | 11 | 84 | 0 | 162 | 1 | 163 | 247 | 0 | 3 | 3 | 0 | ||||||||
| Totals All HSCT/CAR-T/GT | 181 | 1455 | 91 | 1727 | 1 | 2762 | 1 | 2764 | 4491 | 14 | 551 | 565 | 9 | ||||||||
| Paediatric Patients (1st HSCT/CAR-T/GT) | 152 | 101 | 46 | 299 | 0 | 109 | 0 | 109 | 408 | 3 | 48 | 51 | 8 | ||||||||
| #colspan# | |||||||||||||||||||||
| ADDITIONAL INFORMATION: | |
|---|---|
| TOTAL TRANSPLANTS IN 2024 | 4491 |
| TOTALS ABOVE INCLUDE: | |
| DLI'S | 406 |
| CORD BLOOD | 92 |
| UNRELATED DONORS | 1165 |
| RELATED DONORS: (ID SIB = 332, NON ID SIB = 229, TWIN = 1) | 562 |
| #colspan# |
| Table 2a: 2024 UK & ROI Activity by Transplant Type and Cell Source: All HSCTs (Adults and Paediatrics). | ||||||||||||||||||||||||||||||||||||||||||
| 2024 | Allo ID SIB | HAPLO and Other Mismatched Related | Allo TWIN | Allo Unrelated Donor | Auto | Total | CAR-T | Total | Gene Therapy | |||||||||||||||||||||||||||||||||
| All HSCT | BM | PBSC | CB | BM | PBSC | CB | BM | PBSC | BM | PBSC | CB | BM | PBSC | CB | Allo | Auto | HSCT | Allo | Auto | CAR-T | ||||||||||||||||||||||
| UK | 71 | 259 | 0 | 17 | 211 | 0 | 0 | 1 | 80 | 982 | 91 | 1 | 2685 | 1 | 1712 | 2687 | 4399 | 14 | 551 | 565 | 9 | |||||||||||||||||||||
| ROI | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 11 | 1 | 0 | 0 | 77 | 0 | 15 | 77 | 92 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
| Totals | 73 | 259 | 0 | 17 | 212 | 0 | 0 | 1 | 91 | 983 | 91 | 1 | 2762 | 1 | 1727 | 2764 | 4491 | 14 | 551 | 565 | 9 | |||||||||||||||||||||
| Table 2b: 2024 UK & ROI Activity by Transplant Type and Cell Source: First HSCT – Paediatrics Only. | ||||||||||||||||||||||||||||||||||||||||||
| 2024 | Allo ID SIB | HAPLO and Other Mismatched Related | Allo TWIN | Allo Unrelated Donor | Auto | Total | CAR-T | Total | Gene Therapy | |||||||||||||||||||||||||||||||||
| 1ST HSCT | BM | PBSC | CB | BM | PBSC | CB | BM | PBSC | BM | PBSC | CB | BM | PBSC | CB | ALLO | AUTO | HSCT | ALLO | AUTO | CAR-T | ||||||||||||||||||||||
| UK Paeds | 64 | 3 | 0 | 10 | 27 | 0 | 0 | 0 | 65 | 70 | 46 | 0 | 97 | 0 | 285 | 97 | 382 | 3 | 48 | 51 | 8 | |||||||||||||||||||||
| ROI Paeds | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 11 | 0 | 0 | 0 | 12 | 0 | 14 | 12 | 26 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
| Total Paeds | 66 | 3 | 0 | 10 | 28 | 0 | 0 | 0 | 76 | 70 | 46 | 0 | 109 | 0 | 299 | 109 | 408 | 3 | 48 | 51 | 8 | |||||||||||||||||||||
| #colspan# | ||||||||||||||||||||||||||||||||||||||||||
| Abbreviation | Expansion | Abbreviation | Expansion |
|---|---|---|---|
| #colspan# | |||
| ALL | Acute lymphoblastic leukaemia | HSCT | Haematopoietic stem cell transplantation |
| ALLO | Allogeneic stem cell transplant | ID SIB | Identical sibling |
| AML | Acute myeloid leukaemia | MDS | Myelodysplastic syndrome |
| AUTO | Autologous stem cell transplant | MDS/MPN | Combined myelodysplastic syndrome / Myeloproliferative neoplasm |
| BM | Bone marrow | MPN | Myeloproliferative neoplasm |
| BSBMTCT | British Society of Blood and Marrow Transplantation & Cellular Therapy | NHL | Non-Hodgkin lymphoma |
| CAR-T | Chimeric antigen receptor T-cell therapy | NON ID SIB | Non identical sibling |
| CB | Cord blood | PAEDS | Paediatric (children) patients |
| CLL | Chronic lymphocytic leukaemia | PBSC | Peripheral blood stem cell |
| CML | Chronic myeloid leukaemia | PCD | Plasma cell disorder |
| DLI | Donor lymphocyte infusion | PLL | Prolymphocytic leukaemia |
| GT | Gene therapy treatment | ROI | Republic of Ireland |
| HAPLO | Haploidentical donor | SAA | Severe aplastic anaemia |
| HL | Hodgkin lymphoma | UK | United Kingdom |
| #colspan# |